Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower

Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond the separation of its consumer health unit—Chief Financial Officer Joe Wolk described the company’s appetite for M&A as “voracious.”